Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 11/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.64 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | CYSLTR2 | Q9NS75 | 9/20 | 0.62 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.55 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10607508 | 0.93 | CYSLTR1 (0.71) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL7007566 | 0.86 | CYSLTR1 (0.62) | CYSLTR1CYSLTR2GPBAR1 | |
| SCHEMBL9827765 | 0.86 | CYSLTR1 (0.62) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL9031363 | 0.86 | CYSLTR1 (0.66) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL9031944 | 0.86 | CYSLTR1 (0.66) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL7808312 | 0.85 | CYSLTR1 (0.64) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL8736459 | 0.85 | CYSLTR1 (0.71) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL9301876 | 0.84 | CYSLTR1 (0.68) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL8732501 | 0.83 | CYSLTR1 (0.52) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 | |
| SCHEMBL10446560 | 0.82 | CYSLTR1 (0.79) | CYSLTR1FFAR1AKR1B1CYSLTR2GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5051427-A | Antiinflammatory agents and antiallergens | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-09-24 | — | — | US | disclosed |
| EP-0395697-A4 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? | — | 1991-03-13 | — | — | EP | disclosed |
| EP-0395697-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4 | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1990-11-07 | — | — | EP | disclosed |
| US-4920133-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| WO-1989004303-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |